What are the significant differences between the two lower limbs in deep‑vein thrombosis (DVT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Significant Differences Between Lower Limbs in DVT

Calf swelling ≥3 cm larger than the asymptomatic side (measured 10 cm below the tibial tuberosity) is a clinically significant difference that scores 1 point on the Wells score and helps stratify DVT probability. 1

Clinical Assessment of Limb Asymmetry

The Wells score specifically quantifies significant differences between limbs as part of DVT risk stratification:

  • Calf circumference difference ≥3 cm (measured 10 cm below tibial tuberosity) = 1 point
  • Entire leg swelling = 1 point
  • Pitting edema confined to symptomatic leg = 1 point
  • Localized tenderness along deep venous distribution = 1 point
  • Collateral superficial veins (nonvaricose) = 1 point

When both legs are symptomatic, evaluate the MORE symptomatic leg for scoring purposes. 1

Anatomic Distribution Patterns

Left vs. Right Limb Involvement

DVT occurs more frequently in the left lower extremity, with a left-to-right ratio of 1.5:1 overall. 2 This asymmetry becomes more pronounced proximally:

  • Iliac DVT: 2.4:1 left-to-right ratio 3
  • Infrainguinal DVT: 1.3:1 left-to-right ratio 3
  • Isolated infrainguinal DVT: 1.09:1 (nearly equal) 3

The left-sided predominance for proximal DVT likely relates to anatomic compression of the left common iliac vein (May-Thurner syndrome) and undiagnosed iliac vein webs. 3

Bilateral DVT: Critical Prognostic Implications

Bilateral DVT occurs in 19.3% of all DVT cases and carries significantly worse outcomes than unilateral disease. 4 Key differences include:

Mortality and Morbidity:

  • Higher pulmonary embolism rate: 25% vs. lower rates in unilateral DVT 2
  • Higher mortality: 23.1% in bilateral DVT 2
  • Worse 2-year survival: 65-67% for bilateral DVT vs. 72-80% for unilateral DVT 5

Recurrence Risk:

  • Prior DVT history: 38.5% in bilateral cases vs. 20-23% in unilateral 2
  • VTE recurrence rates: 13-13.3% for bilateral vs. 7.7% for unilateral distal DVT 5

Post-thrombotic complications:

  • Significantly higher post-thrombotic syndrome including leg ulceration 2

Risk Factors for Bilateral DVT

Active HIV disease and iliofemoral thrombosis are independent risk factors for bilateral DVT. 4 Malignancy-associated DVT is more frequently proximal and often right-sided, contrasting with the typical left-sided predominance. 3

Diagnostic Implications

Complete duplex ultrasound (CDUS) should evaluate BOTH lower extremities from inguinal ligament to ankle, regardless of unilateral symptoms. 1 This recommendation is critical because:

  • Clinical examination has only 27.2% sensitivity for detecting bilateral thrombosis 4
  • 7% of all patients with DVT symptoms have bilateral disease 4
  • Bilateral evaluation includes spectral Doppler of both common femoral veins to assess symmetry 1

Common Pitfalls

Do not rely solely on clinical examination to exclude contralateral DVT - the high specificity (93.3%) but low sensitivity (27.2%) means bilateral disease is frequently missed clinically. 4

Do not assume equal risk between limbs - the left lower extremity has inherently higher risk for proximal DVT due to anatomic factors, while distal DVT shows more equal distribution. 3

Recognize that bilateral DVT mandates more aggressive monitoring and potentially extended anticoagulation given the substantially elevated risks of PE, mortality, and recurrence. 2, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.